John Lyons Selected Research

John Lyons Research Topics

Disease

18	Neoplasms (Cancer) 03/2022 - 11/2003
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2010 - 07/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 12/2014
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2015 - 08/2012
2	Leukemia 06/2014 - 03/2004
2	Hematologic Neoplasms (Hematological Malignancy) 03/2004 - 12/2003
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2021
1	Diarrhea 12/2020
1	Vomiting 12/2020
1	Fatigue 12/2020
1	Nausea 12/2020
1	Mucositis 12/2020
1	Triple Negative Breast Neoplasms 01/2018
1	Hemorrhage 08/2017
1	Hepatocellular Carcinoma (Hepatoma) 10/2016
1	Fibrosis (Cirrhosis) 10/2016
1	Fatty Liver 10/2016
1	Inflammation (Inflammations) 10/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016
1	Carcinogenesis 08/2015
1	Primary Myelofibrosis (Myelosclerosis) 06/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2012
1	Carcinoma (Carcinomatosis) 03/2012
1	Lung Neoplasms (Lung Cancer) 03/2012
1	Carcinoid Tumor (Carcinoid) 07/2008
1	Body Weight (Weight, Body) 07/2008
1	Pain (Aches) 06/2007
1	Chronic Pancreatitis 06/2007
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2004
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2004
1	Severe Acute Respiratory Syndrome 11/2003
1	Malaria 11/2003
1	Stroke (Strokes) 11/2003
1	Motor Neuron Disease (Primary Lateral Sclerosis) 11/2003

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 12/2020 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2012
5	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 12/2020 - 03/2012
3	guadecitabineIBA 01/2018 - 12/2014
3	Decitabine FDA Link 10/2016 - 12/2003
2	MethyltransferasesIBA 01/2018 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2016
2	Histones (Histone)IBA 10/2016 - 06/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2015 - 03/2012
2	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 08/2012
2	Aurora KinasesIBA 06/2014 - 06/2009
1	Inhibitor of Apoptosis ProteinsIBA 10/2021
1	ASTX-660IBA 10/2021
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Drug CombinationsIBA 01/2018
1	talazoparibIBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Prasugrel Hydrochloride FDA Link 08/2017
1	Clopidogrel (Plavix)FDA Link 08/2017
1	TicagrelorIBA 08/2017
1	omega-Chloroacetophenone (Mace)IBA 08/2017
1	Molecular Chaperones (Chaperone, Molecular)IBA 08/2015
1	Rifabutin (Ansamycin)FDA Link 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 12/2014
1	PlatinumIBA 12/2014
1	Transcription Factors (Transcription Factor)IBA 12/2014
1	DNA AdductsIBA 12/2014
1	Aurora Kinase AIBA 06/2014
1	1- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA 06/2014
1	epothilone B (EPO906)IBA 06/2012
1	vatalanib (PTK787)IBA 06/2012
1	Chromogranin AIBA 05/2012
1	SynaptophysinIBA 05/2012
1	Factor VIII (Coagulation Factor VIII)IBA 05/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2012
1	SaltsIBA 03/2012
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2011
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2011
1	Indicators and Reagents (Reagents)IBA 12/2010
1	Aurora Kinase BIBA 06/2009
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2008
1	ras ProteinsIBA 08/2005
1	mirdametinibIBA 08/2005
1	Sorafenib (BAY 43-9006)FDA Link 08/2005
1	Cytotoxins (Cytolysins)IBA 12/2003
1	A-Form DNA (A-DNA)IBA 12/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 06/2007
2	Aftercare (After-Treatment) 08/2012 - 03/2012
1	Neoadjuvant Therapy 03/2022
1	Esophagectomy 03/2022
1	Cytoreduction Surgical Procedures 12/2009